ESR1 and breast carcinoma: Human triple-negative breast cancer (TNBC) corresponds to the basal-like subtype of breast cancer that is negative for estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2).